Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 1, 2009, Pages 42-48

  Chehadeh, Wassim ^a   Abdella, Nabila ^a,b   Ben Nakhi, Abdullah ^c   Al Arouj, Monira ^c   Al Nakib, Widad ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MUBARAK AL KABEER HOSPITAL   (Kuwait)

^c AL AMIRI HOSPITAL   (Kuwait)

Author keywords

Hepatitis C genotype 4; Risk factors; Sustained virological response; Type 2 diabetes; Viral load

Indexed keywords

ANTIVIRUS AGENT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FAMILY HISTORY; FATTY LIVER; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; VIRUS LOAD;

EID: 58549092990     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05503.x     Document Type: Article

References (47)

1. Caronia S, Taylor K, Pagliaro L et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis c virus infection. Hepatology 1999 30 : 1059 63.
2. Mason AL, Lau JY, Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999 29 : 328 33.
3. Kawaguchi T, Yoshida T, Harada M et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am. J. Pathol. 2004 165 : 1499 508.
4. Abdella N, Al Arouj M, Al-Nakhi A, Al-Assoussi A, Moussa M. Non-insulin-dependent diabetes in Kuwait: prevalence rates and associated risk factors. Diabetes Res. Clin. Pract. 1998 42 : 187 96.
5. Chehadeh W, Sarkhouh HA, Al-Nakib W. Predictors of glucose intolerance in HCV-infected patients with no family history of diabetes. Diabetes Res. Clin. Paract. 2007 77 : 157 8.
6. Huang JF, Dai CY, Hwang SJ et al. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am. J. Gastroenterol. 2007 102 : 1237 43.
7. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin. Proc. 2000 75 : 355 9.
8. Fartoux L, Poujol-Robert A, Guechot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005 54 : 1003 8.
9. Narita R, Abe S, Kihara Y, Akiyama T, Tabaru A, Otsuki M. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J. Hepato.l 2004 41 : 132 8.
10. Zein CO, Levy C, Basu A, Zein NN. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am. J. Gastroenterol. 2005 100 : 48 55.
11. Simo R, Lecube A, Genesca J, Esteban JI, Hernandez C. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diab. Care 2006 29 : 2462 6.
12. Kamal SM, Madwar MA, Peters T et al. Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J. Hepatol. 2000 32 : 172 4.
13. Zylberberg H, Chaix ML, Brechot C. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Ann. Intern. Med. 2000 132 : 845 6.
14. Ray SC, Arthur RR, Carella A et al. Genetic epidemiology of hepatitis C virus throughout Egypt. J. Infect. Dis. 2000 182 : 698 707.
15. Hasan F, Asker H, Al-Khaldi J et al. Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. Am. J. Gastroenterol. 2004 99 : 1733 7.
16. Kamal SM, Turner B, He Q et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 2006 43 : 771 9.
17. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin. Microbiol. Rev. 2000 13 : 223 35.
18. Wali MH, Heydtmann M, Harrison RF et al. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4. Liver Transpl. 2003 9 : 796 804.
19. Nelson RG, Everhart JE, Knowler WC, Bennett PH. Incidence, prevalence and risk factors for non-insulin-dependent diabetes mellitus. Prim. Care 1998 15 : 227 50.
20. Petit JM, Bour JB, Galland-Jos C et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J. Hepatol. 2001 35 : 279 83.
21. Mehta SH, Brancati FL, Strathdee SA et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003 38 : 50 6.
22. Behrendt CE, Ruiz RB. Hyperglycemia among persons with hepatitis C: not the classical diabetic phenotype. Diabetes Res. Clin. Pract. 2006 71 : 68 74.
23. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann. Intern. Med. 2000 133 : 592 9.
24. Bedossa P, Poynard T. The METAVIR Cooperative study group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996 24 : 289 93.
25. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994 20 : 15 20.
26. Abdella N, Al-Nakhi A, Al-Arouj M, Assoussi A, Moussa M. Impact of the 1997 American Diabetes Association criteria on classification of glucose intolerance among Kuwaitis below 50 years of age. Acta Diabetol. 1999 36 : 133 40.
27. World Health Organization. Obesity: preventing and managing the global epidemic. WHO Technical Report Series 1997; No. 894.
28. American Diabetes Association. Clinical practice recommendations. Report of the expert committee on the diagnosis and classification of diabetes. Diab. Care 2003 26 : S1 16.
29. Hu Y, Shahidi A, Park S, Guilfoyle D, Hirshfield I. Detection of extrahepatic hepatitis C virus replication by a novel, highly sensitive, single-tube nested polymerase chain reaction. Am. J. Clin. Pathol. 2003 119 : 95 100.
30. Grimbert S, Valensi P, Levy-Marchal C et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol. Clin. Biol. 1996 20 : 544 8.
31. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J. Hepatol. 2000 32 : 209 17.
32. Hartz AJ Jr., Rupley DC, Kalkhoff RD, Rimm AA. Relationship of obesity to diabetes: influence of obesity level and body fat distribution. Prev. Med. 1983 12 : 351 7.
33. Kissebah AH, Peiris AN. Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 1989 5 : 83 109.
34. Ortiz V, Berenguer M, Rayon JM, Carrasco D, Berenguer J. Contribution of obesity to hepatitis C-related fibrosis progression. Am. J. Gastroenterol. 2002 97 : 2408 14.
35. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999 30 : 1356 62.
36. Main J, Thomas H, Hepatitis C. How should we manage the patient? J. Viral. Hepat. 2004 11 (Suppl. 1 19 22.
37. Lopes EP, Oliveira PM, Silva AE et al. Exacerbation of type 2 diabetes mellitus during interferon-alfa therapy for chronic hepatitis B. Lancet 1994 343 : 244.
38. Imano E, Kanda T, Ishigami Y et al. Interferon induces insulin resistance in patients with chronic active hepatitis C. J. Hepatol. 1998 28 : 189 93.
39. Di Cesare E, Previti M, Russo F et al. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis. Dig. Dis. Sci. 1996 41 : 1672 7.
40. Chen LK, Hwang SJ, Tsai ST, Luo JC, Lee SD, Chang FY. Glucose intolerance in Chinese patients with chronic hepatitis C. World J. Gastroenterol. 2003 9 : 505 8.
41. Yoneda M, Saito S, Ikeda T et al. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J. Viral. Hepat. 2007 14 : 600 7.
42. Delgado-Borrego A, Casson D, Schoenfeld D et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004 77 : 703 10.
43. Muzzi A, Leandro G, Rubbia-Brandt L et al. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J. Hepatol. 2005 42 : 41 6.
44. Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y, Schattner A. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am. J. Gastroenterol. 2003 98 : 2751 6.
45. Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J. Intern. Med. 1999 245 : 621 5.
46. Waris G, Livolsi A, Imbert V, Peyron JF, Siddiqui A. Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. J. Biol. Chem. 2003 278 : 40778 87.
47. Shintani Y, Fujie H, Miyoshi H et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004 126 : 840 8.